Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
4-AcO-DET is believed to be not habit-forming, and the desire to use it may actually decrease with repeated use.
The exact toxic dose is unknown as no formal scientific studies have been conducted. 4-AcO-DET is assumed to have a similar toxicity profile to psilocybin based on structural similarity.
Delusions are listed as a potential cognitive effect during intoxication, but no systematic data exists on intrinsic psychosis risk.
No intrinsic seizure risk has been documented for this substance.
4-AcO-DET was first synthesized in 1958 by Albert Hofmann at the Sandoz laboratories in Switzerland. Despite this early synthesis, the compound remained largely unexplored for decades and has accumulated very little documented history of human usage.…
Controlled under Anlage I of the Betäubungsmittelgesetz (Narcotics Act) since January 24, 1974, as it is classified as an ester of DET. Manufacturing, possession, importation, exportation, purchase, sale, and distribution are prohibited without a license.
Classified as a health hazard under Lagen om förbud mot vissa hälsofarliga varor (Act on the Prohibition of Certain Goods Dangerous to Health) effective November 1, 2005, under regulation SFS 2005:733. Possession and sale are illegal.
Classified as a controlled drug. Possession, production, supply, and importation are prohibited under Turkish drug law.
Not federally scheduled under the Controlled Substances Act. However, as a structural analogue of psilocin (4-HO-DMT), which is a Schedule I substance, sale for human consumption or use for illicit purposes could potentially be prosecuted under the Federal Analogue Act.
Designated as a controlled substance effective July 29, 2015, under national drug control legislation.
Specifically named as a controlled substance under Verzeichnis E since November 1, 2005, pursuant to the Act on the Prohibition of Certain Goods Dangerous to Health.
Controlled as a Class A substance due to its status as an ester of 4-HO-DET, which falls under the tryptamine catch-all clause of the Misuse of Drugs Act 1971. Carries the most severe penalties for possession, production, and supply.
10 sources cited